Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBioingénierie tissulaire [BIOTIS]
dc.contributor.authorETCHEBARNE, Marion
hal.structure.identifierBioingénierie tissulaire [BIOTIS]
dc.contributor.authorFRICAIN, Jean-Christophe
ORCID: 0000-0001-7855-6437
dc.contributor.authorKERDJOUDJ, Halima
dc.contributor.authorDI PIETRO, Roberta
dc.contributor.authorWOLBANK, Susanne
dc.contributor.authorGINDRAUX, Florelle
hal.structure.identifierBioingénierie tissulaire [BIOTIS]
dc.contributor.authorFENELON, Mathilde
dc.date.accessioned2021-12-21T08:37:19Z
dc.date.available2021-12-21T08:37:19Z
dc.date.issued2021-01-01
dc.identifier.issn2296-4185en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/124228
dc.description.abstractEnThanks to their biological properties, amniotic membrane (AM), and its derivatives are considered as an attractive reservoir of stem cells and biological scaffolds for bone regenerative medicine. The objective of this systematic review was to assess the benefit of using AM and amniotic membrane-derived products for bone regeneration. An electronic search of the MEDLINE-Pubmed database and the Scopus database was carried out and the selection of articles was performed following PRISMA guidelines. This systematic review included 42 articles taking into consideration the studies in which AM, amniotic-derived epithelial cells (AECs), and amniotic mesenchymal stromal cells (AMSCs) show promising results for bone regeneration in animal models. Moreover, this review also presents some commercialized products derived from AM and discusses their application modalities. Finally, AM therapeutic benefit is highlighted in the reported clinical studies. This study is the first one to systematically review the therapeutic benefits of AM and amniotic membrane-derived products for bone defect healing. The AM is a promising alternative to the commercially available membranes used for guided bone regeneration. Additionally, AECs and AMSCs associated with an appropriate scaffold may also be ideal candidates for tissue engineering strategies applied to bone healing. Here, we summarized these findings and highlighted the relevance of these different products for bone regeneration.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enamniotic epithelial cells
dc.subject.enamniotic membrane
dc.subject.enamniotic mesenchymal stromal cells
dc.subject.enbone
dc.subject.enbone tissue engineering
dc.subject.ennatural scaffold
dc.subject.enregenerative medicine
dc.title.enUse of Amniotic Membrane and Its Derived Products for Bone Regeneration: A Systematic Review.
dc.title.alternativeFront Bioeng Biotechnolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.3389/fbioe.2021.661332en_US
dc.subject.halSciences du Vivant [q-bio]/Biotechnologiesen_US
dc.identifier.pubmed34046400en_US
bordeaux.journalFrontiers in Bioengineering and Biotechnologyen_US
bordeaux.page661332en_US
bordeaux.volume9en_US
bordeaux.hal.laboratoriesBioingénierie Tissulaire (BioTis) - UMR_S 1026en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.institutionINSERMen_US
bordeaux.institutionCHU de Bordeauxen_US
bordeaux.institutionInstitut Bergoniéen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-03429541
hal.version1
hal.exportfalse
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers%20in%20Bioengineering%20and%20Biotechnology&rft.date=2021-01-01&rft.volume=9&rft.spage=661332&rft.epage=661332&rft.eissn=2296-4185&rft.issn=2296-4185&rft.au=ETCHEBARNE,%20Marion&FRICAIN,%20Jean-Christophe&KERDJOUDJ,%20Halima&DI%20PIETRO,%20Roberta&WOLBANK,%20Susanne&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée